Advancing cell therapies with gene editing at Be Biopharma - Cambridge, MA, US
Senior Scientist at Be Biopharma
Contact Alexis Hubaud
Principal Scientist
Contact Ken-Edwin Aryee
Scientist Cell Therapies
Contact Sarah Leach
Associate Process Engineer B Cell Core
Contact Sidney Steiner
Senior Research Associate
Contact Shivani Bhawsar
Sr. Research Associate
Contact Charuta Yadav
Associate director, Analytical Development and Novel Technologies
Contact Rian Laat
Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.